SOLICITATION NOTICE
68 -- BDT V3.1 RR-5000 & SEQ BUFFER
- Notice Date
- 9/8/2021 11:44:24 AM
- Notice Type
- Solicitation
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- NATIONAL INSTITUTES OF HEALTH NIAID BETHESDA MD 20892 USA
- ZIP Code
- 20892
- Solicitation Number
- RFQ-NIAID-2087823
- Response Due
- 9/23/2021 9:00:00 AM
- Archive Date
- 10/08/2021
- Point of Contact
- Maliaka Pinkney, Phone: 2406695308, Julienne Keiser, Phone: 4063639370
- E-Mail Address
-
maliaka.pinkney@nih.gov, jkeiser@niaid.nih.gov
(maliaka.pinkney@nih.gov, jkeiser@niaid.nih.gov)
- Description
- This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 �Streamlined Procedures for Evaluation and solicitation for commercial Items,� as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-2087823 and the solicitation is issued as a Request for Quotes (RFQ). This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2021-05 March 10, 2021. The North American Industry Classification System (NAICS) code for this procurement is 325413, In-Vitro Diagnostics Substance Manufacturing, with a small business size standard of 1250 employees. The requirement is being competed full and open competition, un-restricted and without a small business set-aside. The Clinical & Molecular Retrovirology Section (CMRS) is part of the National Institute of Allergy and Infectious Diseases (NIAID) that conducts basic research on the role of gamma-delta T cells in the immunopathogenesis of HIV infection. The CMRS studies the role of regulatory genes of HIV on the normal function of human immune competent cells. The lab conducts clinical trials of antiretroviral agents as well as agents used to treat the opportunistic infections and neoplasms of HIV infected individuals; and conducts clinical trials on candidate HIV vaccines. The CMRS lab requires the BigDye Terminator v3.1 which cannot be substituted with an alternative brand as this item is already used in an established protocol. Changing of the brand or item could influence results rendering them uncompilable with previous results. Dr. Hiromi Imamichi�s group, in CMRS, needs the Applied Biosystems BigDye Terminator v3.1 Cycle Sequencing Kit for sanger sequencing of HIV provirus. The group is currently studying the role of Defective HIV provirus in the pathogenesis and treatment of HIV infected patients on cART. Applied Biosystems BigDye Terminator v3.1 Cycle Sequencing Kit (Cat. # 43-374-57) is exclusively manufactured by Thermofisher Co. /Life Techenologies only. Place of Performance: NIH, 9000 Rockville Pike, Bethesda, MD 20892 The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. The award will be based on the lowest price technically acceptable. The technical capability to meet the above requirements and price. The following FAR provisions apply to this acquisition: FAR 52.212-1 Instructions to Offerors Commercial Items (June 2020) FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (FEB 2021) FAR 52.204-7 System for Award Management (Oct 2018) (Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record) FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements � Representation (Jan 2017) 52.204�26 Covered Telecommunications Equipment or Services-Representation (OCT 2020) *** Must complete representation if attached to this solicitation- see attachment 52.204-26 The following FAR contract clauses apply to this acquisition: FAR 52-212-4 Contract Terms and Conditions Commercial Items (OCT 2018) FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (JUL 2021) *The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting. FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (Dec 2013) FAR 52.204-13 System for Award Management Maintenance (Oct 2018) FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (Aug 2020) HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 2015) 52.252-2 -- Clauses Incorporated by Reference. (Feb 1998) This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address: http://farsite.hill.af.mil/vffara.htm By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation ( www.sam.gov). Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax. Submission shall be received not later than September 23, 2021 @ 12:00 PM EST Offers may be e-mailed to Maliaka Pinkney at (maliaka.pinkney@nih.gov). Offers shall include RFQ number in the subject line (RFQ-NIAID-2087823). Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f) All responsible sources may submit an offer that will be considered by this Agency. Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Maliaka Pinkney at maliaka.pinkney@nih.gov.
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/cd917d66ac96499fb0e36b72387e09d0/view)
- Place of Performance
- Address: Bethesda, MD 20892, USA
- Zip Code: 20892
- Country: USA
- Zip Code: 20892
- Record
- SN06126075-F 20210910/210908230133 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |